Advancements in radiotherapy for genitourinary cancers.
作者信息
Miszczyk Marcin
机构信息
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland.
出版信息
Curr Opin Urol. 2025 Sep 1;35(5):541-542. doi: 10.1097/MOU.0000000000001320. Epub 2025 Aug 7.
Abstract
摘要
相似文献
1
Advancements in radiotherapy for genitourinary cancers.泌尿生殖系统癌症放射治疗的进展。
Curr Opin Urol. 2025 Sep 1;35(5):541-542. doi: 10.1097/MOU.0000000000001320. Epub 2025 Aug 7.
2
Incidence, mortality, and risk factors of bladder, kidney, prostate and testicular cancers in China and comparisons with the United States, the United Kingdom, Japan, and the Republic of Korea: an up-to-date overview based on the Global Burden of Disease 2021.中国膀胱癌、肾癌、前列腺癌和睾丸癌的发病率、死亡率及危险因素，以及与美国、英国、日本和韩国的比较：基于《2021年全球疾病负担》的最新综述
Exp Hematol Oncol. 2025 Aug 6;14(1):103. doi: 10.1186/s40164-025-00694-9.
3
Global, regional, and national burden of genitourinary cancers in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年204个国家和地区泌尿生殖系统癌症的全球、区域和国家负担：全球疾病负担研究2021的系统分析
J Natl Cancer Cent. 2025 May 3;5(3):330-345. doi: 10.1016/j.jncc.2025.03.001. eCollection 2025 Jun.
4
Distinct CT imaging features of new liver metastases from primary genitourinary cancers.原发泌尿生殖系统肿瘤新发肝转移的 CT 影像学特征。
Abdom Radiol (NY). 2024 Jul;49(7):2209-2219. doi: 10.1007/s00261-024-04296-7. Epub 2024 May 21.
5
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.强度调制中度低分割放疗与立体定向体部放疗治疗前列腺癌（PACE-C）：一项随机、开放标签、3期、非劣效性试验的早期毒性结果
Lancet Oncol. 2025 Jul;26(7):936-947. doi: 10.1016/S1470-2045(25)00205-0. Epub 2025 Jun 12.
6
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers.新型放射性药物与泌尿生殖系统癌症的诊疗一体化未来
Eur Urol. 2025 Feb;87(2):125-139. doi: 10.1016/j.eururo.2024.09.036. Epub 2024 Oct 20.
7
Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis.高危前列腺癌患者接受低分割与常规分割放疗后的直肠/泌尿毒性：系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2017 Aug;21(16):3563-3575.
8
The role of the urinary microbiome in genitourinary cancers.泌尿微生物群在泌尿生殖系统癌症中的作用。
Nat Rev Urol. 2025 Mar 13. doi: 10.1038/s41585-025-01011-z.
9
Comparative efficacy of non-ablative radiofrequency and promestriene in management of the genitourinary syndrome and sexual dysfunction in cervical cancer survivors: a pilot randomized trial.非消融性射频与普罗雌烯治疗宫颈癌幸存者泌尿生殖综合征及性功能障碍的疗效比较：一项前瞻性随机试验
J Sex Med. 2025 Jun 3;22(6):1043-1052. doi: 10.1093/jsxmed/qdaf083.
10
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials.接受前列腺放疗患者急性毒性与迟发性毒性之间的相互作用：六项随机试验的个体患者数据荟萃分析
Lancet Oncol. 2025 Mar;26(3):378-386. doi: 10.1016/S1470-2045(24)00720-4. Epub 2025 Jan 30.
本文引用的文献
1
Carbon ion radiotherapy as a dose escalation tool in the treatment of primary high-risk prostate cancer.碳离子放疗作为治疗原发性高危前列腺癌的剂量递增工具。
Curr Opin Urol. 2025 Sep 1;35(5):568-573. doi: 10.1097/MOU.0000000000001327. Epub 2025 Jul 17.
2
Artificial intelligence in muscle-invasive bladder cancer: opportunities, challenges, and clinical impact.人工智能在肌层浸润性膀胱癌中的应用：机遇、挑战及临床影响
Curr Opin Urol. 2025 Sep 1;35(5):543-548. doi: 10.1097/MOU.0000000000001309. Epub 2025 Jun 11.
3
Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherapy.前列腺特异性膜抗原PET与多参数MRI相结合用于图像引导放疗的局限性和局部晚期前列腺癌大体肿瘤体积的界定
Curr Opin Urol. 2025 Jul 16. doi: 10.1097/MOU.0000000000001321.
4
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer.放射治疗在前列腺癌根治性治疗后盆腔淋巴结复发中的作用。
Curr Opin Urol. 2025 Sep 1;35(5):574-582. doi: 10.1097/MOU.0000000000001322. Epub 2025 Jul 17.
5
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy.超分割放疗治疗前列腺床肉眼可见复发：聚焦立体定向放疗和近距离放疗
Curr Opin Urol. 2025 Sep 1;35(5):583-589. doi: 10.1097/MOU.0000000000001314. Epub 2025 Jul 4.
6
MR-guided radiotherapy for prostate cancer: an inevitable transition?磁共振引导的前列腺癌放疗：不可避免的转变？
Curr Opin Urol. 2025 Sep 1;35(5):562-567. doi: 10.1097/MOU.0000000000001315. Epub 2025 Jul 4.
7
Adjuvant radiotherapy following radical cystectomy in patients with muscle-invasive bladder cancer: a narrative review.肌层浸润性膀胱癌患者根治性膀胱切除术后的辅助放疗：一项叙述性综述。
Curr Opin Urol. 2025 Sep 1;35(5):549-553. doi: 10.1097/MOU.0000000000001310. Epub 2025 Jun 20.
Zotero 插件